These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 588107)

  • 21. Effects of topical 1-epinephrine and dipivalyl epinephrine on intraocular pressure and pupil size in the normotensive and glaucomatous Beagle.
    Gwin RM; Gelatt KN; Gum GG; Peiffer RL
    Am J Vet Res; 1978 Jan; 39(1):83-6. PubMed ID: 629453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cicatricial entropion associated with chronic dipivefrin application.
    D'Ostroph AO; Dailey RA
    Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):328-31. PubMed ID: 11642488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ocular hypersensitivity to dipivalyl epinephrine by component eye-drop testing.
    Petersen PE; Evans RB; Johnstone MA; Henderson WR
    J Allergy Clin Immunol; 1990 May; 85(5):954-8. PubMed ID: 2332569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic absorption of topical ocularly applied epinephrine and dipivefrin.
    Anderson JA
    Arch Ophthalmol; 1980 Feb; 98(2):350-3. PubMed ID: 7352887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
    Garzia R
    J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans.
    Camras CB; Feldman SG; Podos SM; Christensen RE; Gardner SK; Fazio DT
    Am J Ophthalmol; 1985 Jul; 100(1):169-75. PubMed ID: 3893139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisulfite intolerance manifest as bronchospasm following topical dipivefrin hydrochloride therapy for glaucoma.
    Schwartz HJ; Sher TH
    Arch Ophthalmol; 1985 Jan; 103(1):14-5. PubMed ID: 3977669
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of echothiophate on the biphasic response of rabbit ocular pressure to dipivefrin.
    Mindel JS; Koenigsberg AM; Kharlamb AB; Goldfarb J; Orellana J
    Arch Ophthalmol; 1982 Jan; 100(1):147-51. PubMed ID: 6173032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norepinephrine therapy in patients allergic to or intolerant of epinephrine.
    Bigger JF
    Ann Ophthalmol; 1979 Feb; 11(2):183-6. PubMed ID: 434735
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.
    Hayasaka Y; Hayasaka S; Zhang XY; Nagaki Y
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1142-5. PubMed ID: 11923258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal vascularization and opacification during long-term use of dipivefrin.
    Salminen L; Krootila K; Helin H; Hakala T
    J Ocul Pharmacol Ther; 1995; 11(1):37-40. PubMed ID: 8535955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (Dipivalyl epinephrine)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Apr; 172(4):565-8. PubMed ID: 349251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic and nonenzymatic hydrolysis of D,L-dipivefrin.
    Mindel JS; Cohen G; Barker LA; Lewis DE
    Arch Ophthalmol; 1984 Mar; 102(3):457-60. PubMed ID: 6703997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma.
    Kohn AN; Moss AP; Hargett NA; Ritch R; Smith H; Podos SM
    Am J Ophthalmol; 1979 Feb; 87(2):196-201. PubMed ID: 373450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
    Albracht DC; LeBlanc RP; Cruz AM; Lamping KA; Siegel LI; Stern KL; Kelley EP; Stoecker JF
    Am J Ophthalmol; 1993 Sep; 116(3):307-13. PubMed ID: 8357055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma.
    Krieglstein GK; Leydhecker W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Feb; 205(3):141-6. PubMed ID: 305728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
    Alimgil ML; Erda S; Benian O
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
    [No Abstract]   [Full Text] [Related]  

  • 40. Supersensitivity to topical epinephrine after long-term epinephrine therapy.
    Flach AJ; Kramer SG
    Arch Ophthalmol; 1980 Mar; 98(3):482-3. PubMed ID: 7362503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.